CLDX   $41.24  0.19% Market Closed After Close 41.24 0.0

Celldex Therapeutics Inc
Total Cash 802.32M
totalCashPerShare 12.104
EBITDA -160.19M
Total Debt 2.38M
quickRatio 29.064
currentRatio 29.358
Total Revenue 8.30M
debtToEquity 0.293
Revenue/Share 0.148
ROA -0.17828
ROE -0.27532
grossProfits
freeCashflow -56.81M
operatingCashflow -121.49M
earningsGrowth
revenueGrowth 8.321
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -18.54163
profitMargins 0.0
enterpriseValue 2.13B
forwardPE -15.020408
floatShares 66.10M
sharesOutstanding 66.29M
sharesShort 8.57M
sharesShortPriorMonth 8.40M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.00%
heldPercentInstitutions 1.07%
Short Ratio help_outline 12.03%
shortPercentOfFloat 0.15%
impliedSharesOutstanding
bookValue 12.276
Price To Book help_outline 3.60
earningsQuarterlyGrowth
netIncomeToCommon -150.22M
trailingEps -2.75%
forwardEps -2.94%
enterpriseToEbitda -13.28
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.68 3Q 2024
institutionsCount 268
lastUpdated Sept. 16, 2024, 12:25 p.m.